AMALGAMATED BANK - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 257 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMALGAMATED BANK ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$438
-23.7%
16,376
-2.6%
0.00%
-20.0%
Q1 2024$574
-13.3%
16,817
-26.5%
0.01%0.0%
Q4 2023$662
+2.6%
22,876
-2.2%
0.01%0.0%
Q3 2023$645
-10.8%
23,381
-2.8%
0.01%
-16.7%
Q2 2023$723
-10.2%
24,054
+8.2%
0.01%
-14.3%
Q1 2023$805
-6.2%
22,232
-7.6%
0.01%
-12.5%
Q4 2022$858
-99.9%
24,053
+1.8%
0.01%0.0%
Q3 2022$800,000
+18.0%
23,637
+0.8%
0.01%
+33.3%
Q2 2022$678,000
-10.3%
23,449
+0.3%
0.01%0.0%
Q1 2022$756,000
-47.2%
23,379
-52.4%
0.01%
+20.0%
Q4 2021$1,432,000
+113.7%
49,092
+95.3%
0.01%
-16.7%
Q3 2021$670,000
-15.1%
25,139
-1.9%
0.01%0.0%
Q2 2021$789,000
+255.4%
25,614
+173.1%
0.01%
+50.0%
Q4 2019$222,000
-12.9%
9,379
+1.3%
0.00%
-20.0%
Q3 2019$255,000
-17.7%
9,262
-1.0%
0.01%
-28.6%
Q2 2019$310,000
+11.9%
9,356
+18.5%
0.01%0.0%
Q1 2019$277,000
+8.2%
7,898
+2.3%
0.01%0.0%
Q4 2018$256,000
-46.6%
7,720
-3.6%
0.01%
-41.7%
Q2 2018$479,000
+49.7%
8,007
+14.7%
0.01%
+50.0%
Q1 2018$320,000
+13.5%
6,979
-1.5%
0.01%0.0%
Q4 2017$282,000
+7.6%
7,082
+8.3%
0.01%0.0%
Q3 2017$262,000
-7.7%
6,539
-0.6%
0.01%
-11.1%
Q2 2017$284,0006,5780.01%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
NEA Management Company, LLC 7,641,250$107,207,0007.06%
HealthInvest Partners AB 782,746$10,982,0006.50%
KOPP INVESTMENT ADVISORS LLC 729,960$10,241,0005.51%
Murphy Michael R 1,028,304$14,427,0004.96%
Opaleye Management Inc. 460,000$6,454,0003.18%
ASHFORD CAPITAL MANAGEMENT INC 511,244$7,173,0001.68%
Bruce & Co., Inc. 394,581$5,535,0001.42%
AlphaOne Investment Services, LLC 235,065$3,297,0001.40%
Ranger Investment Management 1,560,453$21,893,0001.23%
NORTHPOINTE CAPITAL LLC 584,753$8,204,0001.07%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders